Does Vaxart's Oral COVID Vaccine Have a Chance?
In the minds of many Americans, vaccines are practically synonymous with shots. However, one small company -- Vaxart (NASDAQ: VXRT) -- is developing an experimental oral COVID-19 vaccine. In this Motley Fool Live video, recorded on Jan. 19, Fool contributors Keith Speights and Brian Orelli answer a viewer's question about whether or not Vaxart's oral COVID-19 vaccine has a chance to succeed.
Source Fool.com
